Watchlist Price Alert

ANI Pharmaceuticals Inc. (ANIP)

NASDAQ: ANIP · Real-Time Price · USD

61.67

2.95 (5.02%)

At close: Jun 02, 2025, 2:32 PM

ANI Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-18.52M	18.78M	-47.9M	-42.6M	-22.55M	6.09M	15.49M	-1.08M	3.93M
Depreciation & Amortization	67.73M	59.79M	59.65M	47.25M	44.64M	44.61M	33.74M	27.93M	22.34M
Stock-Based Compensation	29.34M	20.65M	14.6M	10.49M	12.94M	9.22M	6.78M	6.09M	6.07M
Other Working Capital	n/a	19.79M	4.2M	-7.93M	16.09M	-4.67M	7.62M	1.88M	14.9M
Other Non-Cash Items	18.56M	6.62M	8.99M	5.02M	6.07M	9.42M	10.27M	8.57M	13.97M
Deferred Income Tax	-21.91M	-11.74M	-15.25M	-16.75M	-13.21M	-9.13M	-5.18M	3.56M	-8.91M
Change in Working Capital	-11.19M	24.86M	-51.3M	-84K	-12.63M	-14.58M	5.97M	-5.65M	-9.93M
Operating Cash Flow	64.02M	118.96M	-31.2M	3.32M	15.27M	45.63M	67.07M	39.42M	27.47M
Capital Expenditures	-16.95M	-18.51M	-16.45M	-23.64M	-68.32M	-27.55M	-10.91M	-107.99M	-149.06M
Cash Acquisitions	-401.28M	n/a	-33K	-84.49M	n/a	n/a	-16.47M	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-5M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	12.8M	-9.64M	750K	2.65M	-62.19M	-20.91M	-5.17M	-97.62M	-5M
Investing Cash Flow	-404.72M	-18.51M	-15.74M	-105.48M	-68.32M	-27.55M	-27.38M	-107.99M	-154.06M
Debt Repayment	345.22M	-3M	-3M	99.02M	-534K	115.29M	-2.81M	75M	n/a
Common Stock Repurchased	-10.96M	-4.99M	-1.96M	-890K	-1.52M	-1.03M	-659K	-259K	-2.62M
Dividend Paid	-1.63M	-1.63M	-1.63M	-190K	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-56.83M	-3.5M	1.46M	2.07M	618K	-118.75M	-24.34M	-2.38M	323K
Financial Cash Flow	264.94M	67.44M	-5.13M	194.59M	-1.44M	1.25M	-27.82M	72.36M	-729K
Net Cash Flow	-76.23M	167.89M	-52.07M	92.43M	-54.49M	19.33M	11.88M	3.78M	-127.32M
Free Cash Flow	47.06M	100.45M	-47.66M	-20.32M	-53.05M	18.08M	56.16M	-68.57M	-121.59M